Turkey Swung to September Current-Account Surplus Amid Continued Tourism Boom
By Joshua Kirby
Turkey's current account swung to a surplus in September, boosted by a continued surge in tourism.
The current account booked a surplus of $1.88 billion compared with a deficit of $357 million a month before, according to figures released Monday by the Turkish central bank. It marks the first surplus since June, and only the second in the last two years.
The summer tourism season continued to bring in foreign currency in September, contributing more than $5 billion of a services surplus of $6.25 billion. The country's goods deficit on the other hand continue to see a deficit, at $3.66 billion, though this narrowed from the previous month.
A weak Turkish lira has steadily pushed up import prices in recent years, fuelling rampant inflation and weighing on the trade balance.
The central bank has lifted interest rates markedly in recent months, aiming to put a brake on the decline of the lira, and inflation eased a little in October following months of renewed rises.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
November 13, 2023 02:30 ET (07:30 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software